Management of Persistent Depression with Emerging OCD Features
Rationale for Dose Escalation
- OCD typically requires higher doses of serotonergic agents than depression or anxiety disorders, with treatment duration of at least 8-12 weeks at the optimal dose to determine efficacy 1
- SSRIs and duloxetine show similar efficacy for OCD, so the choice should be based on avoiding unnecessary medication changes in a patient who has partially responded 1
Avoiding the Risks of Switching
- The American College of Physicians and other guideline societies imply that switching to an SSRI would require tapering duloxetine, introducing a new agent, and risking recurrence of the anxiety symptoms that have improved 2
Specific Dosing Protocol
- The recommended treatment duration is at least 8-12 weeks at the optimal dose to determine efficacy, and maintaining 120mg daily for a full 12-week trial at maximum dose before assessing efficacy is suggested 1
Monitoring During Escalation
- Assess for emergence of hypomania or mood destabilization at every visit, particularly given the complex psychiatric history 3
If Duloxetine 120mg Fails After 12 Weeks
- For patients with partial response to medication, add cognitive-behavioral therapy with exposure and response prevention (ERP), which is the gold standard psychotherapy for OCD 1
- CBT with ERP should consist of 10-20 sessions and can be delivered in-person or via internet-based protocols 3
Augmentation Strategies if Monotherapy Insufficient
- Consider aripiprazole augmentation (5-15mg daily) for treatment-resistant OCD, as second-generation antipsychotics are recommended when SSRIs/SNRIs alone are inadequate 3
Critical Pitfalls to Avoid
- Declaring treatment failure before completing at least 8-12 weeks at maximum tolerated dose (120mg) would be premature and could deprive your patient of benefit 1, 3
- With the complex medication history, assess for serotonin syndrome if combining or switching medications 3